午夜视频在线播放,久久久无码精品亚洲A片消消乐

香蕉91成人一区二区三区飘花,91精品人妻一区二区三区蜜桃,四川少妇BBw搡BBBB槡BBBB,国产成人91一区二区三区APP

<noscript id="ccccc"><optgroup id="ccccc"></optgroup></noscript>

CN

CN EN

Latest News

Latest News Media Downloads Video Center

Kexing Biopharm's clinical trial application accepted for human interferon α1b inhalation solution
2022-08-19

2022-08-19

On the evening of August 18, 2022, Kexing Biopharm...
Kexing Biopharm's clinical trial application accepted for another dosage form of human interferon α2b
2022-08-15

2022-08-15

On the evening of August 14, 2022, Kexing Biopharm Co., Ltd. (hereinafter referred to as "the Company" or "Kexing Biopharm") announced that it had recently received the Notice of Acceptance, an administrative license document issued by the National Medical Products Administration (hereinafter referred to as "NMPA"), indicating that its clinical trial application for "Human Interferon α2b Spray" was accepted.
Kexing Biopharm's clinical trial application accepted for "Pegylated Human Granulocyte Colony-stimulating Factor Injection"
2022-08-02

2022-08-02

On the evening of August 1, 2022, Kexing Biopharm Co., Ltd. (hereinafter referred to as "the Company" or "Kexing Biopharm") announced that it had just received the Notice of Acceptance, an administrative license document issued by the National Medical Products Administration (hereinafter referred to as "NMPA"), indicating that its clinical trial application for "Pegylated Human Granulocyte Colony-stimulating Factor Injection" was accepted.
Kexing Biopharm's conference for reviewing operation and management in first half of 2022and planning key tasks for the second half-year held successfully
2022-08-01

2022-08-01

In the face of the complicated political and economic environment in China and overseas as well as the tough situation in the pharmaceutical industry, Kexing Biopharm proposed the working policy themed as "intensely licensing in new products, firmly promoting R&D and innovation, and proactively creating business in new industries" at the beginning of the year, and continuously followed and implemented the policy in the first half-year.
Phase I clinical trial kick-off meeting of Kexing Biopharm's COVID-19 oral drug SHEN26 Capsule held successfully
2022-07-22

2022-07-22

On July 20, 2022, the phase I clinical trial kick-off meeting of SHEN26 Capsule, a small-molecule oral drug against COVID-19 jointly developed by Shenzhen Kexing Pharmaceutical Co., Ltd., a wholly-owned subsidiary of Kexing Biopharm (688136.SH), and Shenzhen Antiv Pharma Co., Ltd., was successfully held in the Second Affiliated Hospital of Anhui Medical University, indicating the official start of the clinical study for the project.

1 2 3 4 5

Support Hotline

0755-26546500
Online Consultation
QR Code

Scan Code Consultation

丰满多毛大隂户XXXHD | 精品孕妇孕交喷水A片 | 人人添人人澡人人爽人人澡 | 四川少妇搡BBBB搡BBB视频网 | 日韩无码免费观看视频 | 一夲道人妻熟女AⅤ深 | 西西大胆一级裸体A片 | 成人免费无码区色情免费 | 国产高潮的无套A片激情视频大全 | 国产精品无码久久久久 | 人人妻人人爱人人爽DⅴD | 91九色人妻大屁股 | 亚洲国精产品二二三三区 | 国产亲子伦XXXXX对白 | 99免费播放视频99 | 极品白丝自慰喷水 | 国产伦精品一区二区三区免.费 | 亚洲AV无码秘蜜桃粉股 | 免费毛片网站在线观看 | 免费观看国产又大又长又粗又黄的A√片 | 凸凹人妻人人澡人人添 | 99无码秘蜜桃人妻一区二区三区 | 2017亚洲阿v天堂 | 欧美午夜A片缴情性影院竹菊影視 | 91熟妇女人妻69丰满少妇 | 国产精品成人在线 | 安徽妇搡BBBB搡BBBB视频 | 四川一级毛片免费播放 | 无码人妻一区二区三区免费京洛会 | 麻豆精品秘国产传媒AV消防 | 亚洲无码在线免费观看 | 丰满人妻的婬乱生活2 | 中文字幕aV无码一区二区三区 | 国产又黄又大又粗视频 | 欧美日韩大陆片一区二区三区 | 欧美精品一区二区少妇免费A片 | 国产一区二区四区在线2021 | 蜜臂AV成人无码久久精品 | 黑人群交亚洲美女 | 91睡熟迷奷系列精品 | 在线观看污视频网站 |

<nav id="c0cc0"><code id="c0cc0"></code></nav>

<noscript id="c0cc0"></noscript>